Last reviewed · How we verify

NCT06784622

Evaluatıon of the Effect of Pulpotomy Treatments Wıth Dıfferent Bıomaterıals on Postoperatıve Paın In Permanent Molars

Not yet recruiting Phase 4 Last updated 20 January 2025
What this trial tests

Phase 4 trial testing Treatment as usual in Acute Pulpitis in 54 participants. Not yet recruiting.

Timeline
1 February 2025
Primary endpoint
1 June 2025
1 July 2025

Quick facts

Lead sponsorTC Erciyes University
PhasePhase 4
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment54
Start date1 February 2025
Primary completion1 June 2025
Estimated completion1 July 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

TC Erciyes University

Who can join

Adults 18 to 65, any sex, with Acute Pulpitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate the results of partial and total pulpotomy with mineral trioxide aggregate (BIO MTA+) and bioceramic sealer (Well Root PT) in terms of pain and vitality in permanent molars with exposed pulp due to caries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Treatment as usual

Trials testing the same drug.

Other recruiting trials for Acute Pulpitis

Currently open trials in the same condition.

Other TC Erciyes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06784622.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing